We are live on
!
Find out more
RIM
RS Investment Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
3.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.36%
1 Year Est. Return
+3.24%
3 Year Est. Return
+50.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.73B
AUM Growth
-$385M
(-3.8%)
Cap. Flow
-$739M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
14.92%
Holding
438
New
62
Increased
134
Reduced
162
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kirby Corp
KEX
|
+$55M |
| 2 |
Integra LifeSciences
IART
|
+$51.1M |
| 3 |
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
+$45.4M |
| 4 |
WBMD
WebMD Health Corp.
WBMD
|
+$43.4M |
| 5 |
Ingevity
NGVT
|
+$39.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Myriad Genetics
MYGN
|
+$81.5M |
| 2 |
Steris
STE
|
+$57.7M |
| 3 |
Red Robin
RRGB
|
+$56.8M |
| 4 |
Dollar General
DG
|
+$52.6M |
| 5 |
Zebra Technologies
ZBRA
|
+$48.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.31% |
| 2 | Healthcare | 15.94% |
| 3 | Financials | 14.68% |
| 4 | Consumer Discretionary | 13.08% |
| 5 | Industrials | 12.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XEC
376
DELISTED
CIMAREX ENERGY CO
XEC
| $21K | ﹤0.01% |
180
| – | – |
|
377
Vermilion Energy
VET
$2.05B
| $19K | ﹤0.01% |
596
| – | – |
|
378
Range Resources
RRC
$9.74B
| $18K | ﹤0.01% |
410
-280
| -41% | -$11.5K |
|
379
Southern Copper
SCCO
$159B
| $15K | ﹤0.01% |
589
| – | – |
|
380
HF Sinclair
DINO
$20B
| $14K | ﹤0.01% |
576
| – | – |
|
381
Helmerich & Payne
HP
$4.32B
| $14K | ﹤0.01% |
+210
| New | +$13K |
|
382
Valero Energy
VLO
$114B
| $12K | ﹤0.01% |
229
| – | – |
|
383
iShares MSCI ACWI ETF
ACWI
$32.7B
| – | – |
-3,739
| Closed | -$210K |
|
384
Ascendis Pharma A/S
ASND
$15.6B
| – | – |
-985,849
| Closed | -$18.3M |
|
385
Avery Dennison
AVY
$13B
| – | – |
-264,848
| Closed | -$19.1M |
|
386
Chubb
CB
$132B
| – | – |
-250,680
| Closed | -$29.9M |
|
387
Cenovus Energy
CVE
$62.3B
| – | – |
-1,110
| Closed | -$14K |
|
388
DigitalBridge
DBRG
$2.98B
| – | – |
-2,453
| Closed | -$111K |
|
|
389
Dollar General
DG
$27.8B
| – | – |
-614,050
| Closed | -$52.6M |
|
390
Liberty Media Series C
FWONK
$23.7B
| – | – |
-1,680,923
| Closed | -$45.3M |
|
|
HOLX
391
DELISTED
Hologic
HOLX
| – | – |
-924,598
| Closed | -$31.9M |
|
392
H&R Block
HRB
$5.59B
| – | – |
-1,220,481
| Closed | -$32.2M |
|
393
ImmunityBio
IBRX
$8.39B
| – | – |
-1,113,237
| Closed | -$9.15M |
|
394
Kimberly-Clark
KMB
$32.6B
| – | – |
-45,545
| Closed | -$6.13M |
|
395
KT
KT
$9.46B
| – | – |
-24,770
| Closed | -$332K |
|
396
L3Harris
LHX
$46.6B
| – | – |
-105,180
| Closed | -$8.19M |
|
397
iShares MSCI China ETF
MCHI
$6.1B
| – | – |
-6,860
| Closed | -$292K |
|
|
MFA
398
MFA Financial
MFA
$855M
| – | – |
-416,640
| Closed | -$11.4M |
|
|
399
Myriad Genetics
MYGN
$361M
| – | – |
-2,178,740
| Closed | -$81.5M |
|
400
Nike
NKE
$53.9B
| – | – |
-99,070
| Closed | -$6.09M |
|
Similar funds
SG
KGI
VAM
FBNAT
CPS
LH
CPM
VFS
RS Investment Management's Q2 2016 Portfolio in Review
As of Q2 2016, RS Investment Management held 438 positions worth $9.73B, down 3.8% from $10.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RS Investment Management withdrew a net $739M in Q2 2016, closing 56 positions and reducing 162 holdings. Its most notable exit was Myriad Genetics, an estimated $81.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, RS Investment Management opened a new position in Kirby Corp worth $52.4M.
- RS Investment Management's largest Q2 2016 buy was Kirby Corp: 839,753 shares worth $52.4M.
- RS Investment Management added most to Allergan plc in Q2 2016, an estimated $36.7M increase.
- RS Investment Management's biggest Q2 2016 reduction was Steris, cutting an estimated $57.7M.
- RS Investment Management fully exited Myriad Genetics in Q2 2016, selling an estimated $81.5M.
- RS Investment Management's ten largest holdings make up 15% of its $9.73B portfolio in Q2 2016.
- RS Investment Management opened 62 new positions and closed 56 in Q2 2016.
- RS Investment Management's portfolio value fell 3.8% quarter-over-quarter to $9.73B.
Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.